Our finding outlines the glutamatergic deficit as a distinct alteration with Dyrk1a overexpression playing a key role in glutamatergic dysfunction and GABA-mediated over-inhibition combining with it to produce the full DS cognitive deficit. The gene discussed is DYRK1A; the disease is Cognitive impairment.